Bourne Advises Endo on Sale of Portfolio of Oral Solid ANDAs
June 29, 2018
June 29, 2018 – Endo International plc (“Endo”, NasdaqGS: ENDP) has sold a portfolio of oral solid ANDAs to an undisclosed buyer. Bourne Partners, a Charlotte-based financial advisory firm focused exclusively in healthcare and life sciences, served as the sole financial advisor to Endo throughout the transaction.
About Endo International plc
Endo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. For more information, visit www.endo.com.